Group Cognitive Behavioural Family Intervention (CBFI) for People With Schizophrenia and Their Families

Schizophrenia Clinical Trial

Official title:

Effectiveness of Group Cognitive Behavioural Family Intervention (CBFI) for People With Schizophrenia and Their Families: A Mixed-method Study

Clinical Trial Details — Status: Withdrawn

Administrative data

• NCT number: NCT04065360
• Other study ID #: CBFI
• Status: Withdrawn
• Phase: N/A
• Start date: January 2021
• Est. completion date: December 2022

Study information

• Verified date: March 2023
• Source: Hospital Authority, Hong Kong
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Cognitive behavioural family intervention (CBFI) is a brief psychosocial intervention that incorporates the model of cognitive behavioural therapy (CBT) into the family context. It builds upon the current trend of family interventions/psychoeducation with refocusing on the cognitive model within the family interpersonal relationship. Existing literature indicates that CBFI may be effective in improving positive and negative symptoms of people diagnosed with schizophrenia immediately following the programme. This mixed-method is to evaluate the feasibility and effectiveness of a CBFI programme for people with schizophrenia and their families in a local context. The findings may accumulate more evidence that CBFI is a brief and effective psychosocial intervention that is adapted to Hong Kong clinical settings.

Recruitment information / eligibility

• Status: Withdrawn
• Enrollment: 0
• Est. completion date: December 2022
• Est. primary completion date: October 2021
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 65 Years

Eligibility

Inclusion Criteria:

Service users

• Diagnosis of schizophrenia-spectrum disorders, based on clinical judgement by the treating clinicians
• Aged 18-65
• Able to communicate in Cantonese Family caregivers
• Aged above 18
• Living with service users
• Able to communicate in Cantonese
• Nominated by the service users Exclusion Criteria: Service users
• Having co-morbidity of learning disability
• Organic/neurological conditions
• Substance misuse disorder Family caregivers
• Having active psychiatric conditions
• Looking after more than one family member suffering from chronic physical or mental illnesses

Related Conditions & MeSH terms

• Mental Disorders
• Psychosis
• Psychotic Disorders
• Schizophrenia

Intervention

Behavioral:
• Group Cognitive behavioural family intervention (CBFI)
four-week, four-session CBT-based family intervention programme
• Usual group psychoeducation
Treatment as usual in the institution studied

Locations

Country	Name	City	State
Hong Kong	Kwai Chung Hospital	Hong Kong

Sponsors (2)

Lead Sponsor	Collaborator
Hospital Authority, Hong Kong	The University of Hong Kong

Country where clinical trial is conducted

Hong Kong, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Qualitative feedback from the clinicians of the concerned wards	Programme evaluation interview	Immediate posttreatment
Secondary	Positive symptoms of service users	Psychotic Symptoms Rating Scales (PSYRATS); 11-item hallucination subscale ranging from 0 to 44; 6-item delusion subscale ranging from 0 to 24	Immediate posttreatment
Secondary	Negative symptoms of service users	Brief Negative Symptom Scale (BNSS); 13-item ranging from 0 to 78	Immediate posttreatment
Secondary	Expressed emotion by service users	Concise Chinese Level of Expressed Emotion Scale (CCLEES); 12-item ranging from 12 to 48	Immediate posttreatment
Secondary	Caregiving experience by family caregivers	Chinese version of Experience of Caregiving Inventory (CECI); 66-item ranging from 0 to 264	Immediate posttreatment
Secondary	Perceived care burden by family caregivers	Family Burden Interview Schedule (FBIS); 25-item ranging from 0 to 50	Immediate posttreatment
Secondary	Mood disturbance by family caregivers	Hospital Anxiety and Depression Scale (HADS); 7-item depression subscale ranging from 0 to 21; 7-item anxiety subscale ranging from 0 to 21	Immediate posttreatment
Secondary	Qualitative feedback from the service users and their families	Semi-structured focus group interview	Immediate posttreatment